Northeast Investment Management Has $7.59 Million Stock Holdings in The Clorox Company (NYSE:CLX)

Northeast Investment Management lessened its stake in The Clorox Company (NYSE:CLX) by 4.9% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 51,547 shares of the company’s stock after selling 2,677 shares during the quarter. Northeast Investment Management’s holdings in Clorox were worth $7,590,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Redwood Park Advisors LLC bought a new stake in Clorox in the fourth quarter worth approximately $26,000. Millstone Evans Group LLC bought a new stake in Clorox in the fourth quarter worth approximately $31,000. Wood Tarver Financial Group LLC bought a new stake in Clorox in the fourth quarter worth approximately $31,000. Asset Planning Inc bought a new stake in Clorox in the fourth quarter worth approximately $32,000. Finally, GKV Capital Management Co. Inc. bought a new stake in Clorox in the fourth quarter worth approximately $32,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insider Buying and Selling at Clorox

In related news, Director Pierre R. Breber purchased 4,000 shares of Clorox stock in a transaction on Wednesday, May 7th. The stock was purchased at an average cost of $136.57 per share, with a total value of $546,280.00. Following the acquisition, the director now directly owns 4,000 shares in the company, valued at approximately $546,280. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 0.57% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have commented on CLX shares. Barclays decreased their target price on shares of Clorox from $134.00 to $129.00 and set an “underweight” rating for the company in a research report on Wednesday, May 7th. UBS Group decreased their target price on shares of Clorox from $176.00 to $154.00 and set a “neutral” rating for the company in a research report on Thursday, April 17th. Morgan Stanley decreased their target price on shares of Clorox from $165.00 to $150.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 6th. Citigroup decreased their price objective on shares of Clorox from $165.00 to $150.00 and set a “neutral” rating for the company in a report on Monday, April 14th. Finally, Wells Fargo & Company decreased their price objective on shares of Clorox from $145.00 to $142.00 and set an “equal weight” rating for the company in a report on Tuesday, May 6th. Three analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $151.23.

Clorox Price Performance

Shares of Clorox stock opened at $126.75 on Wednesday. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The Clorox Company has a fifty-two week low of $126.40 and a fifty-two week high of $171.37. The firm has a fifty day moving average price of $135.76 and a two-hundred day moving average price of $149.21. The company has a market cap of $15.62 billion, a PE ratio of 34.63, a price-to-earnings-growth ratio of 2.62 and a beta of 0.54.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Monday, May 5th. The company reported $1.45 earnings per share for the quarter, missing analysts’ consensus estimates of $1.57 by ($0.12). Clorox had a net margin of 6.38% and a return on equity of 316.87%. The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.74 billion. During the same period last year, the company earned $1.71 earnings per share. Clorox’s revenue for the quarter was down 8.0% on a year-over-year basis. Analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.